201 related articles for article (PubMed ID: 25934338)
1. New approaches for cancer immunotherapy.
Karlitepe A; Ozalp O; Avci CB
Tumour Biol; 2015 Jun; 36(6):4075-8. PubMed ID: 25934338
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy.
Baxevanis CN; Perez SA; Papamichail M
Cancer Immunol Immunother; 2009 Mar; 58(3):317-24. PubMed ID: 18704409
[TBL] [Abstract][Full Text] [Related]
3. Immune checkpoint blockade: the hope for immunotherapy as a treatment of lung cancer?
Brahmer JR
Semin Oncol; 2014 Feb; 41(1):126-32. PubMed ID: 24565586
[TBL] [Abstract][Full Text] [Related]
4. Glycoconjugate Nanoparticle-Based Systems in Cancer Immunotherapy: Novel Designs and Recent Updates.
Barchi JJ
Front Immunol; 2022; 13():852147. PubMed ID: 35432351
[TBL] [Abstract][Full Text] [Related]
5. Immunologic biomarkers as correlates of clinical response to cancer immunotherapy.
Disis ML
Cancer Immunol Immunother; 2011 Mar; 60(3):433-42. PubMed ID: 21221967
[TBL] [Abstract][Full Text] [Related]
6. Cancer biotherapy: review and prospect.
Liu Q; Ma H
Clin Exp Med; 2024 May; 24(1):114. PubMed ID: 38801637
[TBL] [Abstract][Full Text] [Related]
7. International Symposium: Trailblazing in Cancer Immunotherapy, October 29-31, 2017, Pamplona, Spain.
Berraondo P; Aznar MA; Perez-Ruiz E; Rodriguez-Ruiz ME; Castañon E; Perez-Gracia JL; Melero I
Cancer Immunol Immunother; 2018 Nov; 67(11):1809-1813. PubMed ID: 30182281
[No Abstract] [Full Text] [Related]
8. CIMT 2010: report on the eighth annual meeting of the Association for Cancer Immunotherapy, May 26-28, 2010, Mainz, Germany.
Singh SK; Laske K; Gouttefangeas C; Britten CM; Welters MJ
Cancer Immunol Immunother; 2011 Mar; 60(3):443-50. PubMed ID: 21104411
[No Abstract] [Full Text] [Related]
9. Current status and future directions of cancer immunotherapy.
Zhang H; Chen J
J Cancer; 2018; 9(10):1773-1781. PubMed ID: 29805703
[TBL] [Abstract][Full Text] [Related]
10. Report on the first international symposium on cancer biology (ISCB), November 14-16, 2007, at the National Institute of Immunology, New Delhi, India.
Suri A
Cancer Immunol Immunother; 2009 Feb; 58(2):311-6. PubMed ID: 18584172
[No Abstract] [Full Text] [Related]
11. Synopsis of the 5th annual Cancer Vaccines and Immunotherapy Colloquium at Walker's Cay.
Mitchell MS; Kast WM
Cancer Immunol Immunother; 2003 Oct; 52(10):655-60. PubMed ID: 12942201
[No Abstract] [Full Text] [Related]
12. Editorial: Non-cellular immunotherapies in pediatric malignancies.
Alexander S; Harker-Murray P; Hayashi RJ
Front Immunol; 2024; 15():1379278. PubMed ID: 38449864
[No Abstract] [Full Text] [Related]
13. Advances in strategies and methodologies in cancer immunotherapy.
Lam SS; Zhou F; Hode T; Nordquist RE; Alleruzzo L; Raker J; Chen WR
Discov Med; 2015 Apr; 19(105):293-301. PubMed ID: 25977192
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy Approaches in Cancer Treatment.
Klener P; Otáhal P; Lateckova L; Klener P
Curr Pharm Biotechnol; 2015; 16(9):771-81. PubMed ID: 26087990
[TBL] [Abstract][Full Text] [Related]
15. Cancer immunotherapy: harnessing the immune system to battle cancer.
Yang Y
J Clin Invest; 2015 Sep; 125(9):3335-7. PubMed ID: 26325031
[TBL] [Abstract][Full Text] [Related]
16. Cancer immunotherapy. Neo approaches to cancer vaccines.
Delamarre L; Mellman I; Yadav M
Science; 2015 May; 348(6236):760-1. PubMed ID: 25977539
[No Abstract] [Full Text] [Related]
17. Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacy.
Draghiciu O; Lubbers J; Nijman HW; Daemen T
Oncoimmunology; 2015 Jan; 4(1):e954829. PubMed ID: 25949858
[TBL] [Abstract][Full Text] [Related]
18. Tumor antigen-targeting monoclonal antibody-based immunotherapy: Orchestrating combined strategies for the development of long-term antitumor immunity.
Michaud HA; Eliaou JF; Lafont V; Bonnefoy N; Gros L
Oncoimmunology; 2014 Oct; 3(9):e955684. PubMed ID: 25941618
[TBL] [Abstract][Full Text] [Related]
19. Cancer and the Immune System: Basic Concepts and Targets for Intervention.
Pardoll D
Semin Oncol; 2015 Aug; 42(4):523-38. PubMed ID: 26320058
[TBL] [Abstract][Full Text] [Related]
20. Classifying Cancers Based on T-cell Infiltration and PD-L1.
Teng MW; Ngiow SF; Ribas A; Smyth MJ
Cancer Res; 2015 Jun; 75(11):2139-45. PubMed ID: 25977340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
